Literature DB >> 9045685

Cloning of the human phospholipase C-gamma1 promoter and identification of a DR6-type vitamin D-responsive element.

Z Xie1, D D Bikle.   

Abstract

The 5'-flanking region of the human phospholipase C-gamma1 gene was isolated from a human P1 genomic DNA library. The S1-nuclease mapping and primer extension analysis revealed that there is a single transcriptional start site located at 135 bases upstream from the translation start codon in the human phospholipase C-gamma1 gene. DNA sequence analysis showed that the sequence around the transcriptional start site is very GC-rich and has no TATA box. The fragment +135 to -877 in the 5'-flanking region of the human phospholipase C-gamma1 gene was subcloned into a luciferase reporter vector. The chimeric gene produced a high level of luciferase activity and responded to 1,25-(OH)2D3 in transiently transfected human keratinocytes. Deletion and mutation studies of the fragment +135 to -877 demonstrated a vitamin D-responsive element that contains a motif arranged as two direct repeats separated by 6 bases (DR6), AGGTCAgaccacTGGACA, located between -786 and -803 base pairs. Incubation of the oligonucleotide containing the DR6 with keratinocyte nuclear extracts produced a specific protein-DNA complex that shifted to a higher molecular weight form upon the addition of an antibody specific to the 1,25-(OH)2D3 receptor. Therefore, the 5'-flanking region of the human phospholipase C-gamma1 gene confers promoter activity and contains a DR6-type vitamin D-responsive element that mediates, at least in part, the enhanced expression of this gene in human keratinocytes by 1, 25-(OH)2D3.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1997        PMID: 9045685     DOI: 10.1074/jbc.272.10.6573

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  The nonskeletal effects of vitamin D: an Endocrine Society scientific statement.

Authors:  Clifford J Rosen; John S Adams; Daniel D Bikle; Dennis M Black; Marie B Demay; JoAnn E Manson; M Hassan Murad; Christopher S Kovacs
Journal:  Endocr Rev       Date:  2012-05-17       Impact factor: 19.871

2.  A humanized mouse model of hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia.

Authors:  Seong Min Lee; Joseph J Goellner; Charles A O'Brien; J Wesley Pike
Journal:  Endocrinology       Date:  2014-08-22       Impact factor: 4.736

Review 3.  Extraskeletal actions of vitamin D.

Authors:  Daniel D Bikle
Journal:  Ann N Y Acad Sci       Date:  2016-07       Impact factor: 5.691

Review 4.  Protective actions of vitamin D in UVB induced skin cancer.

Authors:  Daniel D Bikle
Journal:  Photochem Photobiol Sci       Date:  2012-12       Impact factor: 3.982

5.  Vitamin D controls T cell antigen receptor signaling and activation of human T cells.

Authors:  Marina Rode von Essen; Martin Kongsbak; Peter Schjerling; Klaus Olgaard; Niels Odum; Carsten Geisler
Journal:  Nat Immunol       Date:  2010-03-07       Impact factor: 25.606

Review 6.  Novel mechanisms for the vitamin D receptor (VDR) in the skin and in skin cancer.

Authors:  Daniel D Bikle; Yuko Oda; Chia-Ling Tu; Yan Jiang
Journal:  J Steroid Biochem Mol Biol       Date:  2014-10-31       Impact factor: 4.292

Review 7.  Vitamin D and the skin: Physiology and pathophysiology.

Authors:  Daniel D Bikle
Journal:  Rev Endocr Metab Disord       Date:  2012-03       Impact factor: 6.514

8.  Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling.

Authors:  Meggan E Keith; Erika LaPorta; JoEllen Welsh
Journal:  Mol Carcinog       Date:  2013-05-16       Impact factor: 4.784

Review 9.  Vitamin D receptor, a tumor suppressor in skin.

Authors:  Daniel D Bikle
Journal:  Can J Physiol Pharmacol       Date:  2014-12-08       Impact factor: 2.273

Review 10.  The vitamin D receptor: a tumor suppressor in skin.

Authors:  Daniel D Bikle
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.